Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926653 · ClinicalTrials.gov registry record
Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
A clinical trial of Depression, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 76
- Enrollment target
- 1
- Study location
NCT00926653 is a study of Depression that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 76 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00926653, a study of Depression, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine differences in activity of the anterior cingulate cortex, a brain area involved in emotion and cognitive regulation, between older adults with and without depression.
Conditions Studied
Interventions
- DRUG Escitalopram
Study Locations (1)
New York
- New York Presbyterian-Weill Cornell Medical College - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00926653
The ClinicalTrials.gov registry entry for NCT00926653 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Escitalopram is the first listed.
NCT00926653 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00926653 about?
NCT00926653 is a clinical study titled "Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression". This study will examine differences in activity of the anterior cingulate cortex, a brain area involved in emotion and cognitive regulation, between older adults with and without depression.
What is the current status of trial NCT00926653?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2005-07. Estimated completion is 2010-05.
What conditions does trial NCT00926653 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00926653?
The interventions under investigation include: Escitalopram (DRUG).
Who is sponsoring clinical trial NCT00926653?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00926653 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.